Prognostic Impact of Preoperative Assessment of Muscle Mass and Strength in Surgically Resected Lung Cancer
Anticancer Research · 2024
DOI: 10.21873/anticanres.16868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Shusuke Kurihara und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, National Hospital Organization Mito Medical Center, Ibaraki, Japan; shusukekurihara@outlook.jp. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung.
Abstract (Originalsprache)
BACKGROUND/AIM: The association between resected non-small cell lung cancer (NSCLC) and long-term outcomes of muscle mass depletion and muscle weakness has also not been well documented. This study evaluated whether muscle mass depletion assessed by bioelectrical impedance analysis (BIA) and low muscle strength assessed by the peak expiratory flow rate as a percentage of predicted value (%PEFR) were associated with surgical outcomes in patients with resected NSCLC. PATIENTS AND METHODS: This retrospective study included 219 patients with resected NSCLC between 2016 and 2021. The cutoff value for muscle mass depletion was according to guidelines, for low muscle strength, we defined by receiver operating characteristics analysis for recurrence-free survival (RFS). Survival analysis was performed, and postoperative outcomes were compared. RESULTS: A total of 76 patients (34.7%) had muscle mass depletion, and 114 patients (52.1%) had low muscle strength. Muscle mass depletion and low muscle strength were independent poor prognostic factors for overall survival [hazard ratio (HR)=2.631, p=0.003; HR=1.983, p=0.044] and RFS (HR=3.120, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, National Hospital Organization Mito Medical Center, Ibaraki, Japan; shusukekurihara@outlook.jp.
- Department of Surgery, National Hospital Organization Mito Medical Center, Ibaraki, Japan.
- Department of Respiratory Medicine, National Hospital Organization Mito Medical Center, Ibaraki, Japan.
- Department of Pathology, National Hospital Organization Mito Medical Center, Ibaraki, Japan.
- Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Mito, Japan.
Zitieren
APA
Kurihara, S., Nakamura, R., Yoneyama, S., Takase, S., Hatori, T., Yamagishi, T., Numata, T., Ota, K., Yanai, H., Endo, T., Inadome, Y., Satoh, H., Muto, R., & Fukunaga, K. (2024). Prognostic Impact of Preoperative Assessment of Muscle Mass and Strength in Surgically Resected Lung Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16868
Vancouver
Kurihara S, Nakamura R, Yoneyama S, Takase S, Hatori T, Yamagishi T, et al. Prognostic Impact of Preoperative Assessment of Muscle Mass and Strength in Surgically Resected Lung Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.16868
BibTeX
@article{Kurihara2024,
author = {Kurihara, Shusuke and Nakamura, Ryota and Yoneyama, Satoshi and Takase, Shiho and Hatori, Takashi and Yamagishi, Tetsuya and Numata, Takeshi and Ota, Kyoko and Yanai, Hidetoshi and Endo, Takeo and Inadome, Yukinori and Satoh, Hiroaki and Muto, Ryo and Fukunaga, Kiyoshi},
title = {Prognostic Impact of Preoperative Assessment of Muscle Mass and Strength in Surgically Resected Lung Cancer},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16868}
}
EUVIMED